Product Information
KLOR-CON 8 MEQ TABLET is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $0.1181 per EA under NDC 00245531501. Its NADAC has been published 144 times since Jul 10, 2019.
FDA first approved this application on Apr 17, 1986. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245531501
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019123FDA Approved
4/17/1986
TE Code
AB2
On Market Since
4/17/1986
Pharmacological Classes
Price Statistics
The NADAC for KLOR-CON 8 MEQ TABLET has been published 144 times since Jul 10, 2019, and over the history we have for it it has declined 71.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1181 per EA |
|---|---|
| All-time high | $0.4102 (Oct 16, 2019) |
| All-time low | $0.1181 (Aug 19, 2026) |
| 52-week high | $0.2078 |
| 52-week low | $0.1181 |
| Median price | $0.2185 |
| Average price | $0.2282 |
| Largest weekly change | -40.7% (Feb 18, 2026) |
| Weeks tracked | 144 |
| Tracking since | Jul 10, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
potassium chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KLOR-CON 8 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KLOR-CON 8 MEQ TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1181 per EA (NDC 00245531501), effective Sep 30, 2026.
How has the price of KLOR-CON 8 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for KLOR-CON 8 MEQ TABLET has declined 71.2%. It has been tracked across 144 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for KLOR-CON 8 MEQ TABLET?
Since Jul 10, 2019, the NADAC for KLOR-CON 8 MEQ TABLET has ranged from a low of $0.1181 (Aug 19, 2026) to a high of $0.4102 (Oct 16, 2019), with a median of $0.2185 per EA.
Are there cheaper alternatives to KLOR-CON 8 MEQ TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 8 MEQ TABLET, is $0.1028 per EA — about 13% below KLOR-CON 8 MEQ TABLET.
Who manufactures KLOR-CON 8 MEQ TABLET?
KLOR-CON 8 MEQ TABLET (NDC 00245531501) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.